Navigation Links
UNT Health Science Center's Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
Date:7/3/2009

FORT WORTH, Texas, July 3 /PRNewswire-USNewswire/ -- In groundbreaking research, scientists at the University of North Texas Health Science Center at Fort Worth have determined that rapid estrogen administration can protect the brain following brain injury. These findings are now being tested on human trauma patients in North Texas.

James Simpkins, Ph.D., UNT Health Science Center chair of the Department of Pharmacology and Neuroscience, and Jane Wigginton, M.D., Department of Surgery, Division of Emergency Medicine at UT Southwestern Medical Center of Dallas, are translating these animal studies of the protective effects of rapid estrogen treatment to human patients with severe traumatic brain injury and hemorrhagic shock.

"Our animal research has demonstrated that rapid estrogen intervention protects the brain following injury, including stroke or sudden cardiac arrest," Simpkins said. "Now, UT Southwestern and Parkland Health and Hospital System are advancing our research from the UNT Health Science Center to these studies in human subjects. If we can administer these drugs to trauma victims very early, I believe that we can protect the brain and increase survival."

Simpkins' studies in animals found that rapidly administering a single dose of estrogen, a strong anti-oxidant and an anti-inflammatory drug, following a stroke increases brain cell survival by up to 65 percent. Estrogens delivered intravenously post injury may have similar effects on people with traumatic brain injury. "We know these substances can protect the brain and believe them safe for use in this patient population," Simpkins said.

The clinical trials are based on now hundreds of scientific publications from Simpkins' group and others demonstrating the protective effects of estrogens in acute brain injury. Simpkins leads a large National Institutes of Health-funded program of research to discover substances that can protect the brain from injury. This is the first major clinical study to emanate from these basic science studies at the University of North Texas Health Science Center at Fort Worth.

Estrogens are made in large amounts by young women, but only in small amounts by men. Prior studies have suggested that young women are more resistant to brain trauma injury than are older, post-menopausal women and men. This apparent resistance of young women to brain trauma may be because of their higher estrogen levels. These current studies of the effects of rapid estrogen administration on patients with traumatic brain injury and hemorrhagic shock will be a test of this proposal.

In 1994, Simpkins discovered that estrogens were protective to nerve cells and subsequently has demonstrated that, if administered soon after brain injury in animals, estrogens can protect nerve cells and reduce neurological deficits. Application of these discoveries to human subjects awaited the interactions of Simpkins with the pioneering clinical research of Wigginton, who is now the first to take estrogens into clinical trials for acute brain injury and hemorrhagic shock.

University of North Texas Health Science Center

The University of North Texas Health Science Center comprises the Texas College of Osteopathic Medicine, the Graduate School of Biomedical Sciences, the School of Public Health, and the School of Health Professions. Key research areas include aging and Alzheimer's disease, cancer and physical medicine. This year, the Texas College of Osteopathic Medicine was named a top 50 medical school in primary care by U.S. News & World Report for the eighth consecutive year. "Fort Worth's medical school and more" contributes more than $400 million to the Tarrant County and Texas economies annually. For more information, go to http://www.hsc.unt.edu/.


'/>"/>
SOURCE University of North Texas Health Science Center/Fort Worth
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 2016 Les ... la première endoprothèse à double thérapie au ... portant sur les membres inférieurs et la ... entreprise mondiale spécialisée dans la fourniture de ... a élargi son portefeuille pour inclure des ...
(Date:5/23/2016)... PUNE, India , May 23, 2016 ... is spread across 163 pages, profiles 12 companies and ... 280 tables and figures on the industry and its ... study that is comprehensive in nature, details the current ... of the industry including definitions, classifications, applications and industry ...
(Date:5/23/2016)... , May 23, 2016 The World Health ... PrePex device to include adolescents aged 13 years, and ... can be offered for adult and adolescent males in the ... . PrePex was the first male circumcision device to ... MedTech,s CEO, Eddy Horowitz said: " The ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... Researchers from SUNY State College of Optometry won ... on visual evoked potential and human attention. The article, VEP and Human Attention: ... NOVA™ ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to ...
(Date:5/25/2016)... TX (PRWEB) , ... May 25, 2016 , ... ... the United States, named Dr. Anh Tat Nguyen, as the Medical Director of its ... the facility Medical Director of our new DeSoto location,” said Dr. James M. Muzzarelli, ...
(Date:5/25/2016)... New Jersey (PRWEB) , ... May 25, 2016 , ... ... specialized technology firm will be selling the device branded as Stern’s Real Time ... is geared to bedbugs to the hotel and motel industry, colleges for use in ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... According to ... that a group of people randomly assigned to reduce the amount of calories they ... 12 percent drop in body weight enjoyed better sleep, improved quality of life, and ...
(Date:5/24/2016)... ... 24, 2016 , ... BTC Media, a leading digital currency ... to be held in Nashville, Tennessee on September 7, 2016. , The conference ... the event will host teams from around the world, competing to build the ...
Breaking Medicine News(10 mins):